Function of HSP90 and p23 in the Telomerase Complex of Thyroid Tumors

Author： Boltze Carsten Schneider-Stock Regine Roessner Albert Quednow Claudia Hoang-Vu Cuong

ISSN： 0344-0338

Source： Pathology Research and Practice, Vol.199, Iss.9, 2003-10, pp. : 573-579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p53 and p21^WAF1 Expression in Lymphocytic Thyroiditis and Thyroid Tumors

By Okayasu I. Osakabe T. Onozawa M. Mikami T. Fujiwara M.

Clinical Immunology, Vol. 88, Iss. 2, 1998-08 ,pp. : 183-191

Academic Press

Access to resources Recommend Favorite

Hsp90 inhibitors as novel cancer chemotherapeutic agents

By Neckers L.

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite

Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution

Current Molecular Medicine, Vol. 12, Iss. 9, 2012-11 ,pp. : 1108-1124

Bentham Science Publishers

Access to resources Recommend Favorite

Elevated Levels of the 90 kDa Heat Shock Protein (hsp90) in SLE Correlate with Levels of IL-6 and Autoantibodies to hsp90

By Ripley B.J.M. Isenberg D.A. Latchman D.S.

Journal of Autoimmunity, Vol. 17, Iss. 4, 2001-12 ,pp. : 341-346

Academic Press

Access to resources Recommend Favorite

Human Recombinant Antibody to HSP90: A Natural Partner in Combination Therapy

Current Molecular Medicine, Vol. 5, Iss. 4, 2005-06 ,pp. : 403-411

Bentham Science Publishers

Access to resources Recommend Favorite